In addition, CBX7 activity has been reported to be negatively correlated to malignancy grade in breast [8], thyroid [9], pancreatic cancer [10], prostate cancer [11], bladder cancer [12], lung cancer [13] and colon cancer [14]. Here, CBX7 is linked to prostate cancer.